Practical support for medical-device manufacturers: strengthen quality systems, validate processes and prepare for scale.
Where we work
Devices
Class I, IIa, IIb and III medical devices and in vitro diagnostics, from single-use disposables to electromechanical systems
Frameworks
ISO 13485:2016, FDA QMSR (21 CFR Part 820), EU MDR 2017/745 and IVDR 2017/746, ISO 14971:2019
Scope
Quality, regulatory and manufacturing, from development and design transfer to series production and post-market
Based in
Bratislava, Slovakia. We support manufacturers across Central Europe and the wider EU, on site and remotely
About TGMed
Precision. Put to work.
TGMed helps medical-device manufacturers turn quality and regulatory requirements into practical operating systems and clearer production decisions.
TG MED s.r.o. is an independent medical-device consulting company based in Bratislava, Slovakia, established in 2014. We work with manufacturers of medical devices and in vitro diagnostics on the three things that decide whether a product can be made, sold and kept on the market: a quality management system that works day to day, manufacturing processes that are validated and capable, and regulatory documentation that stays current.
Requirements are only useful once they run on the production floor. We identify gaps, agree priorities and support implementation with your team, so that the procedures you document are the procedures your people actually follow. Our consultants have held quality, regulatory and manufacturing responsibilities inside device companies, and we size every engagement to the device, the risk class and the stage your production has reached.
Who we work with
Quality and regulatory leaderswho need a quality management system that holds up in daily operation, in notified-body audits and in FDA inspections, not only on paper.
Operations and production directorswho need validated, capable processes, documented control plans and a supply chain they can account for.
Founders preparing to scalewho need to move from prototype or pilot to series production without losing control of cost, capacity or compliance.
Services
Six areas, one connected scope.
Quality, regulatory and manufacturing problems rarely stay in one department. Each service below names what we assess, how we work and what you receive.
Operational excellence and Lean / Six Sigma
Reduce waste and variation in regulated production without weakening control. Lean and Six Sigma methods work in medical-device manufacturing when every change is assessed for its effect on validated processes, design controls and the quality system.
We map the value stream of a product family, quantify scrap, rework and waiting time, and agree with your team which improvements are worth the change control they require. Results are measured against a documented baseline, not estimated.
Typical deliverables
Value-stream map with agreed improvement priorities
Kaizen events with documented outcomes and owners
Control plans and reaction plans linked to your quality system
Baseline and follow-up measurement of scrap, rework and cycle time
Manufacturing process optimisation and validation
Show that your processes consistently produce conforming product, with evidence an auditor can follow. Process validation (IQ, OQ, PQ) is required under ISO 13485:2016 clause 7.5.6 and the FDA QMSR wherever the output of a process cannot be fully verified by inspection.
We define what must be validated and what can be verified, write protocols with acceptance criteria that match the risk, run capability studies and document the result so that revalidation triggers are clear when equipment, materials or settings change.
Typical deliverables
Validation master plan, IQ / OQ / PQ protocols and reports
Process capability studies (Cp, Cpk) with defined acceptance criteria
Test method validation and measurement system analysis
Automation readiness assessment and revalidation triggers
Supply chain management and resilience
Qualify suppliers and reduce single-source risk for critical components. Purchased parts, sterilisation services and contract manufacturers are part of your device's conformity, and ISO 13485 expects supplier controls proportionate to that risk.
We classify suppliers by criticality, set up qualification and monitoring records, assess where a single source or a long lead time threatens supply, and build traceability from incoming material to finished device and distributed lot.
Typical deliverables
Supplier classification, qualification and evaluation records
Risk assessment of critical and single-source components
Quality agreements and incoming-inspection plans
Traceability procedures from incoming material to finished device
Quality management system operations
Run a quality management system that works day to day, not only during audits. A QMS under ISO 13485:2016 and the FDA QMSR has to carry design changes, CAPA, complaints and supplier issues through production without stopping it.
We assess the system against the standard and against how your people actually work, close the gaps that matter, prepare you for notified-body audits and FDA inspections, and integrate QMS processes with production planning and purchasing.
Typical deliverables
Gap analysis against ISO 13485:2016 and FDA QMSR (21 CFR Part 820)
CAPA, nonconformance and complaint-handling processes that close
Audit preparation, internal audits and management review inputs
Integration of QMS processes with production and purchasing
Scale-up and commercialisation support
Move from pilot to series production with capacity, cost and technology transfer under control. Scaling a medical device exposes every assumption made in development: supplier capacity, process windows, labour content and the cost of quality.
We build the capacity plan, identify bottlenecks before they stop the line, structure design transfer and technology transfer with acceptance criteria, and model unit cost by product and volume so pricing decisions rest on numbers.
Typical deliverables
Capacity plan and bottleneck analysis
Design transfer and technology transfer plans with acceptance criteria
Cost model by product and volume
Production readiness review before launch
Regulatory strategy and compliance advisory
Plan the route to market and keep technical documentation current as requirements change. The EU MDR and IVDR, the FDA QMSR and the transition to new standards have raised the volume and the quality of evidence manufacturers must maintain.
We define the classification and the regulatory pathway for each market, structure technical documentation and 510(k) or PMA submissions, plan clinical evaluation and post-market surveillance, and keep the documentation aligned with the product you actually ship.
Typical deliverables
Classification and regulatory pathway assessment (EU, US)
FDA 510(k) or PMA strategy and submission planning
EU MDR and IVDR technical documentation and GSPR checklists
Clinical evaluation, PMS and PMCF planning and documentation
How we work
Assess, agree, implement, document.
Every engagement follows the same four steps. You know at each stage what is being done, by whom, and what you will receive.
01
Assess
We review your documentation, processes and data, on site where it matters, and name the gaps against the requirements that apply to your device, its risk class and its markets.
02
Agree priorities
Together we decide what to address first, in what scope, and who owns each action. You receive a written plan with deliverables and timing before work starts.
03
Implement with your team
Our specialists work alongside your people, so that changes are understood, adopted and maintained after we leave. Training is part of the work, not an extra.
04
Document and hand over
Each change is recorded in your quality system with the evidence behind it, ready for your next internal audit, notified-body audit or FDA inspection.
Why TGMed
Senior specialists, not generalists.
The person you meet in the first discussion is the person who does the work.
Frameworks we work in
ISO 13485:2016Quality management systems for medical devices, including design and development, production and servicing
FDA QMSR21 CFR Part 820, in force since 2 February 2026; incorporates ISO 13485:2016 by reference and replaces the former QSR
EU MDR / IVDRRegulations (EU) 2017/745 and 2017/746: classification, CE marking, technical documentation, clinical evaluation and post-market surveillance
ISO 14971:2019Risk management for medical devices, applied across design, production and the supply chain
Lean / Six SigmaApplied within the limits of a validated, controlled process and under change control
Senior specialists lead each engagement
Our consultants have held quality, regulatory and manufacturing responsibilities inside medical-device companies. We do not hand work down to junior teams.
We describe the work we control
We prepare the evidence, procedures and records. We do not promise audit results or regulatory approvals, because those decisions belong to auditors, notified bodies and authorities.
One partner across quality, regulatory and manufacturing
A validation gap, a supplier problem and a QMS finding are often the same problem seen from three sides. Our scope covers all three.
Documentation written to be used
Every deliverable is written for the people who will use it: procedures your operators can follow, records an auditor can trace, and every acronym introduced once.
Leadership
Who you will be working with
PG
Pavel Grinshpun
Chief Executive Officer, TG MED s.r.o.
Pavel Grinshpun leads TGMed and is the first point of contact for new engagements. He scopes each project personally and stays involved from the initial assessment to the hand-over of documentation.
Which standards and regulations does TGMed work with?
ISO 13485:2016 for quality management systems, the FDA Quality Management System Regulation (QMSR, 21 CFR Part 820), the EU Medical Device Regulation 2017/745 and In Vitro Diagnostic Regulation 2017/746, and ISO 14971:2019 for risk management. For process validation we follow the GHTF/IMDRF guidance that both ISO 13485 and the FDA reference.
What changed with the FDA QMSR, and does it affect us?
Since 2 February 2026 the QMSR replaces the former Quality System Regulation and incorporates ISO 13485:2016 by reference. Manufacturers that sell in the United States need to align their quality system documentation, terminology and records with ISO 13485 and with the FDA-specific requirements that remain, such as labelling and packaging controls and complaint files. A gap assessment is usually the first step.
What does process validation (IQ, OQ, PQ) involve?
Installation qualification confirms that equipment is installed as specified, operational qualification establishes the process window in which conforming product is produced, and performance qualification demonstrates that the process is stable and capable under production conditions. We write the validation master plan and protocols, define acceptance criteria proportionate to the risk, run the studies with your team and document the results and revalidation triggers.
Do you work with start-ups and small manufacturers?
Yes. Many of our engagements are with companies moving from prototype or pilot to series production for the first time. We size the scope to the device, the risk class and the stage you are at, and we prioritise what is needed for the next milestone rather than building everything at once.
Where does TGMed work?
We are based in Bratislava, Slovakia, and work on site with manufacturers across Central Europe and the wider European Union. Assessment, documentation and follow-up are often done remotely; validation, audits and implementation work happen where your production is.
Do you guarantee audit or certification results?
No. We prepare the evidence, procedures and records and make sure your team can defend them. Decisions on certification, CE marking and FDA clearance belong to notified bodies, auditors and authorities, and no consultant can promise them.
How does an engagement start?
With a discussion of your device, your production stage and the challenge you need to resolve. We then propose a written scope with deliverables and timing. Work follows our four steps: assess, agree priorities, implement with your team, document and hand over.
Contact
Discuss your project
Tell us about your device, production stage and the challenge you need to resolve. We will tell you whether and how we can help, and propose a scope. A first discussion is free of charge and without obligation.